<DOC>
	<DOCNO>NCT00344565</DOCNO>
	<brief_summary>The purpose study test whether cognitive behavioral therapy ( CBT ) medication call modafinil , approve treat sleep disorder , help individual abuse cocaine .</brief_summary>
	<brief_title>A Placebo-Controlled Double-Blind Combined Treatment Modafinil CBT Cocaine Dependence</brief_title>
	<detailed_description>Chronic cocaine abuse document produce cognitive impairment various domain . The observed cognitive deficit substance abuse population include , restrict , attention , concentration , verbal nonverbal memory , problem solve abstract reasoning . Our recent study ( IRB Protocol # 3998 ) demonstrate cocaine dependent participant cognitive deficit show : 1 ) negatively effect retention 2 ) impede ability drug abuser benefit cognitive behavioral therapy- relapse prevention ( CBT-RP ) require participant attend novel stimulus , integrate new information exist store , translate information behavior change ( Aharonovich , Hasin &amp; Nunes , 2003 ; Aharonovich et al , press ) . Furthermore , toxic effect cocaine together withdrawal symptom , fatigue hypersomnia make difficult fully engage psychosocial intervention include CBT-RP . Recent finding indicate cocaine dysregulates reward-related glutamate pathway ( Dackis &amp; O'Brien , 2003 ; Kalivas et al , 2003 ) . Modafinil medication know improve attention , increase wakefulness , energy , alertness part increase glutamate level . In light work negative affect cognitive impairment treatment outcomes , test cognitive enhance medication act glutamate pathway novel promise strategy improve treatment cocaine dependence . Modafinil approve sleep disorder relatively safe medication cocaine-dependent participant low abuse potential show promise double blind placebo control trial cocaine dependence ( Rush et al , 2002 ; Jasinski , 2000 , Dackis et al , 2005 ) . We therefore propose double blind placebo control 12-week exploratory pilot study modafinil , `` wakefulness agent , '' conjunction session CBT-RP enhance motivational interviewing component .</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Meets DSM IV criterion current cocaine dependence seek treatment . Used cocaine least eight day past month report episodic binge large amount cocaine ( least $ 150 worth ) least twice per month Able give inform consent comply study procedure . Meets DSM IV criterion current mood disorder past current mania ( i.e . bipolar disorder ) , schizophrenia psychotic disorder transient psychosis due drug abuse . Baseline 21 item Hamilton Depression Scale score ≥ 15 History seizure Chronic organic mental disorder . Significant current suicidal risk . Pregnancy , lactation , failure sexually active female participant use adequate contraceptive method . Unstable physical disorder , might make participation hazardous hypertension , hepatitis , participant mildly elevate AST ALT level ( &lt; 3 X upper limit normal acceptable ) , diabetes . Coronary vascular disease indicate history , suspect abnormal EKG history cardiac symptom . Current use prescribe psychotropic medication . Current use medication interact modafinil : Tricyclic antidepressant ; MOA Inhibitors ; diazepam ; phenytoin medication contain Ethinyl Estradiol Known hypersensitivity modafinil Currently meet DSMIV criterion narcolepsy Currently meet DSMIV criterion ADHD Currently meet DSMIV criterion opioid sedativehypnotic dependence . Currently meet criterion DSMIV alcohol dependence evidence clinically significant physiological dependence need medically supervise detoxification . Current cannabis dependence identify main problem—i.e . participant current DSMIV cannabis dependence eligible , long cocaine identify participant primary substance problem seek treatment . Gross visual auditory impairment First language English receive NO formal education Englishspeaking school</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>